CfPA-The Center for Professional Advancement, New Brunswick, NJ
March 21-23, 2016
Who Should Attend?
This course is intended for individuals from:
• Formulation and Process Development/Validation
• Regulatory Affairs, QA, QC
• Analytical Methods Development
• Package Development/Engineering
• Manufacturing and Technical Support
• Project Management and Planning
Participants will benefit by gaining a better understanding of the complexities of technology transfer of various dosage forms in the pharmaceutical industry. Course Description
|
|
|
Invited Speakers:
|
|
| Walter G. Chambliss, Ph.D.; Professor of Pharmaceutics, University of Mississippi |
Walter G. Chambliss, Ph.D., is Director of Technology Management and Professor of Pharmaceutics at the University of Mississippi where he is responsible for managing the intellectual property of the University. He received a B.S. in Pharmacy, a M.S. in Pharmaceutics and a Ph.D. in Pharmaceutics from the University of Mississippi. He joined the University as Associate Director in the National Center for Natural Products Research. He worked for 17 years in research and development in the pharmaceutical industry at G.D. Searle, Bristol-Myers and Schering-Plough where he was Vice President of R&D for the HealthCare Products Division. He has extensive experience in formulation development and process development of a wide variety of dosage forms. Dr. Chambliss is a Fellow of the American Pharmaceutical Association and an active member of APhA-APRS, AAPS, the Licensing Executive Society and the Association of University Technology Managers and has authored or co-authored over twenty publications including three book chapters in pharmaceutical research.
| Mukund “Mike” Yelvigi; Founder and Principal, Center for Pharmaceutical Integration, LLC. New Jersey |
Mukund (Mike) Yelvigi is founder & principal at Center for Pharmaceutical Integration LLC, which provides consultation service to the industry in the area of CMC support & Technology Integration and Transfers (mergers & acquisitions). He retired as Sr. Director and Head of CMC Therapeutic Area Management function at Pfizer/Wyeth Inc. NY. He has over 30 years extensive experience in formulation, process development/scale-up, and has successfully launched several products globally. He obtained his undergraduate degree in Pharmacy from Bombay University and graduate degree from Philadelphia College of Pharmacy.
He is an adjunct Assistant Professor of Pharmaceutics at the School of Pharmacy, U of Miss and an active member of AAPS, ISPE, AAiPS, FIP. He was the Chairperson of the AAPS Manufacturing Science & Engineering section.
Additional Faculty
Michael J. Valazza, PVice President of Business Development, Catalent Pharma Solutions
|
|
Interactive case studies based on real examples will allow participants to develop strategies and plans in a team environment.